{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:32:16Z","timestamp":1791077536046,"version":"4.1.0"},"reference-count":67,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Human herpesvirus 8 (HHV-8) is etiologically associated with Kaposi sarcoma (KS), the most common AIDS-associated malignancy. Previous results indicate that the HHV-8 viral transactivator ORF50 interacts synergistically with Tat protein in the transactivation of human immunodeficiency virus (HIV) long terminal repeat (LTR), leading to increased cell susceptibility to HIV infection. Here, we analyze the effect of HHV-8 infection on HIV replication in monocyte-macrophage and endothelial cells, as potential targets of coinfection. Primary or transformed monocytic and endothelial cells were infected with a cell-free HHV-8 inoculum and subsequently infected with lymphotropic or monocytotropic strains of HIV. The results show that HHV-8 coinfection markedly increases HIV replication in both cell types. HHV-8 infection induces also HIV reactivation in chronically infected cell lines and in peripheral blood mononuclear cells (PBMCs) from patients with asymptomatic HIV, suggesting the possibility that similar interactions might take place also in vivo. Furthermore, coinfection is not an essential condition, since contiguity of differently infected cells is sufficient for HIV reactivation. The results suggest that HHV-8 might be a cofactor for HIV progression and that HHV-8-infected endothelial cells might play a relevant role in transendothelial HIV spread. (Blood. 2005;106:2790-2797)<\/jats:p>","DOI":"10.1182\/blood-2005-04-1390","type":"journal-article","created":{"date-parts":[[2005,6,24]],"date-time":"2005-06-24T00:44:32Z","timestamp":1119573872000},"page":"2790-2797","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":50,"title":["Human herpesvirus 8 enhances human immunodeficiency virus replication in acutely infected cells and induces reactivation in latently infected cells"],"prefix":"10.1182","volume":"106","author":[{"given":"Elisabetta","family":"Caselli","sequence":"first","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Galvan","sequence":"additional","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Cassai","sequence":"additional","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Caruso","sequence":"additional","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sighinolfi","sequence":"additional","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Di Luca","sequence":"additional","affiliation":[{"name":"From the Section of Microbiology, Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara, Italy; the Department of Microbiology, University of Brescia, Brescia, Italy; and the Division of Infectious Diseases, S. Anna Hospital, Ferrara, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021215445499900_REF1","doi-asserted-by":"crossref","unstructured":"Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science.1994;266: 1865-1869.","DOI":"10.1126\/science.7997879"},{"key":"2020021215445499900_REF2","unstructured":"Ganem D. Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr Clin Top Infect Dis.1998;18: 237-251."},{"key":"2020021215445499900_REF3","doi-asserted-by":"crossref","unstructured":"Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med.1995;332: 1186-1191.","DOI":"10.1056\/NEJM199505043321802"},{"key":"2020021215445499900_REF4","doi-asserted-by":"crossref","unstructured":"Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood.1995;86: 1276-1280.","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276"},{"key":"2020021215445499900_REF5","doi-asserted-by":"crossref","unstructured":"Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med.2000;342: 1027-1038.","DOI":"10.1056\/NEJM200004063421407"},{"key":"2020021215445499900_REF6","doi-asserted-by":"crossref","unstructured":"Luppi M, Barozzi P, Santagostino G, et al. Molecular evidence of organ-related transmission of Kaposi sarcoma-associated herpesvirus or human herpesvirus-8 in transplant patients. Blood.2000;96: 3279-3281.","DOI":"10.1182\/blood.V96.9.3279"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Barozzi P, Luppi M, Facchetti F, et al. Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors. Nat Med.2003;9: 554-561.","DOI":"10.1038\/nm862"},{"key":"2020021215445499900_REF8","doi-asserted-by":"crossref","unstructured":"Shepherd FA, Maher E, Cardella C, et al. Treatment of Kaposi's sarcoma after solid organ transplantation. J Clin Oncol.1997;15: 2371-2377.","DOI":"10.1200\/JCO.1997.15.6.2371"},{"key":"2020021215445499900_REF9","doi-asserted-by":"crossref","unstructured":"Akula SM, Naranatt PP, Walia NS, Wang FZ, Fegley B, Chandran B. Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol.2003;77: 7978-7990.","DOI":"10.1128\/JVI.77.14.7978-7990.2003"},{"key":"2020021215445499900_REF10","doi-asserted-by":"crossref","unstructured":"Blasig C, Zietz C, Haar B, et al. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol.1997;71: 7963-7968.","DOI":"10.1128\/JVI.71.10.7963-7968.1997"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Foreman KE, Friborg J Jr, Kong WP, et al. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma. N Engl J Med.1997;336: 163-171.","DOI":"10.1056\/NEJM199701163360302"},{"key":"2020021215445499900_REF12","doi-asserted-by":"crossref","unstructured":"Bechtel JT, Liang Y, Hvidding J, Ganem D. Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells. J Virol.2003;77: 6474-6481.","DOI":"10.1128\/JVI.77.11.6474-6481.2003"},{"key":"2020021215445499900_REF13","doi-asserted-by":"crossref","unstructured":"Gao SJ, Kingsley L, Li M, et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med.1996;2: 925-928.","DOI":"10.1038\/nm0896-925"},{"key":"2020021215445499900_REF14","doi-asserted-by":"crossref","unstructured":"Kedes DH, Operskalski E, Busch M, Kohn R, Flood J, Ganem D. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med.1996;2: 918-924.","DOI":"10.1038\/nm0896-918"},{"key":"2020021215445499900_REF15","doi-asserted-by":"crossref","unstructured":"Whitby D, Luppi M, Barozzi P, Boshoff C, Weiss RA, Torelli G. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst.1998;90: 395-397.","DOI":"10.1093\/jnci\/90.5.395"},{"key":"2020021215445499900_REF16","doi-asserted-by":"crossref","unstructured":"Schatz O, Monini P, Bugarini R, et al. Kaposi's sarcoma-associated herpesvirus serology in Europe and Uganda: multicentre study with multiple and novel assays. J Med Virol.2001;65: 123-132.","DOI":"10.1002\/jmv.2011"},{"key":"2020021215445499900_REF17","doi-asserted-by":"crossref","unstructured":"Dedicoat M, Newton R. Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma. Br J Cancer.2003;88: 1-3.","DOI":"10.1038\/sj.bjc.6600745"},{"key":"2020021215445499900_REF18","doi-asserted-by":"crossref","unstructured":"Suchankova A, Stankova M, Roubalova K, Vandasova J, Bruckova M. Seroprevalence of HHV 8 antibodies among the general population and HIV positive persons in the Czech Republic. J Clin Virol.2003;28: 70-76.","DOI":"10.1016\/S1386-6532(02)00265-2"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Gambus G, Bourboulia D, Esteve A, et al. Prevalence and distribution of HHV-8 in different sub-populations, with and without HIV infection, in Spain. AIDS.2001;15: 1167-1174.","DOI":"10.1097\/00002030-200106150-00012"},{"key":"2020021215445499900_REF20","doi-asserted-by":"crossref","unstructured":"Osmond DH, Buchbinder S, Cheng A, et al. Prevalence of Kaposi sarcoma-associated herpesvirus infection in homosexual men at beginning of and during the HIV epidemic. JAMA.2002;287: 221-225.","DOI":"10.1001\/jama.287.2.221"},{"key":"2020021215445499900_REF21","doi-asserted-by":"crossref","unstructured":"Dukers NH, Rezza G. Human herpesvirus 8 epidemiology: what we do and do not know. AIDS.2003;17: 1717-1730.","DOI":"10.1097\/00002030-200308150-00001"},{"key":"2020021215445499900_REF22","doi-asserted-by":"crossref","unstructured":"Sturzl M, Wunderlich A, Ascherl G, et al. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia.1999;13(suppl 1): S110-112.","DOI":"10.1038\/sj.leu.2401323"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Staskus KA, Zhong W, Gebhard K, et al. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol.1997;71: 715-719.","DOI":"10.1128\/JVI.71.1.715-719.1997"},{"key":"2020021215445499900_REF24","doi-asserted-by":"crossref","unstructured":"Renne R, Zhong W, Herndier B, et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med.1996;2: 342-346.","DOI":"10.1038\/nm0396-342"},{"key":"2020021215445499900_REF25","doi-asserted-by":"crossref","unstructured":"Casper C, Nichols WG, Huang ML, Corey L, Wald A. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood.2004;103: 1632-1634.","DOI":"10.1182\/blood-2003-05-1721"},{"key":"2020021215445499900_REF26","doi-asserted-by":"crossref","unstructured":"Laney AS, Dollard SC, Jaffe HW, et al. Repeated measures study of human herpesvirus 8 (HHV-8) DNA and antibodies in men seropositive for both HHV-8 and HIV. AIDS.2004;18: 1819-1826.","DOI":"10.1097\/00002030-200409030-00011"},{"key":"2020021215445499900_REF27","doi-asserted-by":"crossref","unstructured":"Aoki Y, Tosato G. Neoplastic conditions in the context of HIV-1 infection. Curr HIV Res.2004;2: 343-349.","DOI":"10.2174\/1570162043351002"},{"key":"2020021215445499900_REF28","doi-asserted-by":"crossref","unstructured":"Gallo RC. The enigmas of Kaposi's sarcoma. Science.1998;282: 1837-1839.","DOI":"10.1126\/science.282.5395.1837"},{"key":"2020021215445499900_REF29","doi-asserted-by":"crossref","unstructured":"Aoki Y, Giovanna T. HIV-1 Tat enhances KSHV infectivity. Blood.2004;104: 810-814.","DOI":"10.1182\/blood-2003-07-2533"},{"key":"2020021215445499900_REF30","doi-asserted-by":"crossref","unstructured":"Varthakavi V, Browning PJ, Spearman P. Human immunodeficiency virus replication in a primary effusion lymphoma cell line stimulates lytic-phase replication of Kaposi's sarcoma-associated herpesvirus. J Virol.1999;73: 10329-10338.","DOI":"10.1128\/JVI.73.12.10329-10338.1999"},{"key":"2020021215445499900_REF31","doi-asserted-by":"crossref","unstructured":"Merat R, Amara A, Lebbe C, de The H, Morel P, Saib A. HIV-1 infection of primary effusion lymphoma cell line triggers Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation. Int J Cancer.2002;97: 791-795.","DOI":"10.1002\/ijc.10086"},{"key":"2020021215445499900_REF32","doi-asserted-by":"crossref","unstructured":"Harrington W Jr, Sieczkowski L, Sosa C, et al. Activation of HHV-8 by HIV-1 tat. Lancet.1997;349: 774-775.","DOI":"10.1016\/S0140-6736(05)60199-7"},{"key":"2020021215445499900_REF33","doi-asserted-by":"crossref","unstructured":"Suligoi B, Dorrucci M, Uccella I, Andreoni M, Rezza G. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters. J Med Virol.2003;69: 182-187.","DOI":"10.1002\/jmv.10281"},{"key":"2020021215445499900_REF34","unstructured":"Chandra A, Demirhan I, Massambu C, et al. Cross-talk between human herpesvirus 8 and the transactivator protein in the pathogenesis of Kaposi's sarcoma in HIV-infected patients. Anticancer Res.2003;23: 723-728."},{"key":"2020021215445499900_REF35","doi-asserted-by":"crossref","unstructured":"Hyun TS, Subramanian C, Cotter MA 2nd, Thomas RA, Robertson ES. Latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus interacts with Tat and activates the long terminal repeat of human immunodeficiency virus type 1 in human cells. J Virol.2001;75: 8761-8771.","DOI":"10.1128\/JVI.75.18.8761-8771.2001"},{"key":"2020021215445499900_REF36","doi-asserted-by":"crossref","unstructured":"Caselli E, Menegazzi P, Bracci A, Galvan M, Cassai E, Di Luca D. Human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 interacts synergistically with the tat gene product in transactivating the human immunodeficiency virus type 1 LTR. J Gen Virol.2001;82: 1965-1970.","DOI":"10.1099\/0022-1317-82-8-1965"},{"key":"2020021215445499900_REF37","doi-asserted-by":"crossref","unstructured":"Caselli E, Galvan M, Santoni F, et al. Human herpesvirus-8 (Kaposi's sarcoma-associated virus) ORF50 increases in vitro cell susceptibility to human immunodeficiency virus type 1 infection. J Gen Virol.2003;84: 1123-1131.","DOI":"10.1099\/vir.0.18799-0"},{"key":"2020021215445499900_REF38","doi-asserted-by":"crossref","unstructured":"Caselli E, Galvan M, Cassai E, Di Luca D. Transient expression of human herpesvirus-8 (Kaposi's sarcoma-associated herpesvirus) ORF50 enhances HIV-1 replication. Intervirology.2003;46: 141-149.","DOI":"10.1159\/000071454"},{"key":"2020021215445499900_REF39","doi-asserted-by":"crossref","unstructured":"Roan F, Inoue N, Offermann MK. Activation of cellular and heterologous promoters by the human herpesvirus 8 replication and transcription activator. Virology.2002;301: 293-304.","DOI":"10.1006\/viro.2002.1582"},{"key":"2020021215445499900_REF40","doi-asserted-by":"crossref","unstructured":"Deng H, Chu JT, Rettig MB, Martinez-Maza O, Sun R. Rta of the human herpesvirus 8\/Kaposi sarcoma-associated herpesvirus up-regulates human interleukin-6 gene expression. Blood.2002;100: 1919-1921.","DOI":"10.1182\/blood-2002-01-0015"},{"key":"2020021215445499900_REF41","doi-asserted-by":"crossref","unstructured":"Biswas P, Delfanti F, Bernasconi S, et al. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood.1998;91: 258-265.","DOI":"10.1182\/blood.V91.1.258"},{"key":"2020021215445499900_REF42","doi-asserted-by":"crossref","unstructured":"Zaitseva M, Lee S, Lapham C, et al. Interferon gamma and interleukin 6 modulate the susceptibility of macrophages to human immunodeficiency virus type 1 infection. Blood.2000;96: 3109-3117.","DOI":"10.1182\/blood.V96.9.3109"},{"key":"2020021215445499900_REF43","doi-asserted-by":"crossref","unstructured":"Caruso A, Rotola A, Comar M, et al. HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines. J Med Virol.2002;67: 528-533.","DOI":"10.1002\/jmv.10133"},{"key":"2020021215445499900_REF44","doi-asserted-by":"crossref","unstructured":"Arvanitakis L, Mesri EA, Nador RG, et al. Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV\/HHV-8) in the absence of Epstein-Barr virus. Blood.1996;88: 2648-2654.","DOI":"10.1182\/blood.V88.7.2648.bloodjournal8872648"},{"key":"2020021215445499900_REF45","doi-asserted-by":"crossref","unstructured":"Sundstrom C, Nilsson K. Establishment and characterization of a human histiocytic lymphoma cell line (U-937). Int J Cancer.1976;17: 565-577.","DOI":"10.1002\/ijc.2910170504"},{"key":"2020021215445499900_REF46","doi-asserted-by":"crossref","unstructured":"Folks TM, Justement J, Kinter A, Dinarello CA, Fauci AS. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science.1987;238: 800-802.","DOI":"10.1126\/science.3313729"},{"key":"2020021215445499900_REF47","doi-asserted-by":"crossref","unstructured":"Folks TM, Justement J, Kinter A, et al. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J Immunol.1988;140: 1117-1122.","DOI":"10.4049\/jimmunol.140.4.1117"},{"key":"2020021215445499900_REF48","doi-asserted-by":"crossref","unstructured":"Caselli E, Baricordi OR, Melchiorri L, Bellini F, Ponzin D, Bruni A. Inhibition of DNA synthesis in peripheral blood mononuclear cells treated with phosphatidylserines containing unsaturated acyl chains. Immunopharmacology.1992;23: 205-213.","DOI":"10.1016\/0162-3109(92)90027-A"},{"key":"2020021215445499900_REF49","doi-asserted-by":"crossref","unstructured":"Vicenzi E, Panina-Bodignon P, Vallanti G, Di Lucia P, Poli G. Restricted replication of primary HIV-1 isolates using both CCR5 and CXCR4 in Th2 but not in Th1 CD4(+) T cells. J Leukoc Biol.2002;72: 913-920.","DOI":"10.1189\/jlb.72.5.913"},{"key":"2020021215445499900_REF50","doi-asserted-by":"crossref","unstructured":"Mengozzi M, De Filippi C, Transidico P, et al. Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood.1999;93: 1851-1857.","DOI":"10.1182\/blood.V93.6.1851.406k12_1851_1857"},{"key":"2020021215445499900_REF51","doi-asserted-by":"crossref","unstructured":"Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium.2000;7: 223-242.","DOI":"10.3109\/10623320009072210"},{"key":"2020021215445499900_REF52","doi-asserted-by":"crossref","unstructured":"Fan ST, Hsia K, Edgington TS. Upregulation of human immunodeficiency virus-1 in chronically infected monocytic cell line by both contact with endothelial cells and cytokines. Blood.1994;84: 1567-1572.","DOI":"10.1182\/blood.V84.5.1567.1567"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Gilles PN, Lathey JL, Spector SA. Replication of macrophage-tropic and T-cell-tropic strains of human immunodeficiency virus type 1 is augmented by macrophage-endothelial cell contact. J Virol.1995;69: 2133-2139.","DOI":"10.1128\/JVI.69.4.2133-2139.1995"},{"key":"2020021215445499900_REF54","doi-asserted-by":"crossref","unstructured":"Borghi MO, Panzeri P, Shattock R, Sozzani S, Dobrina A, Meroni PL. Interaction between chronically HIV-infected promonocytic cells and human umbilical vein endothelial cells: role of proinflammatory cytokines and chemokines in viral expression modulation. Clin Exp Immunol.2000;120: 93-100.","DOI":"10.1046\/j.1365-2249.2000.01186.x"},{"key":"2020021215445499900_REF55","doi-asserted-by":"crossref","unstructured":"Varthakavi V, Smith RM, Deng H, Sun R, Spearman P. Human immunodeficiency virus type-1 activates lytic cycle replication of Kaposi's sarcoma-associated herpesvirus through induction of KSHV Rta. Virology.2002;297: 270-280.","DOI":"10.1006\/viro.2002.1434"},{"key":"2020021215445499900_REF56","doi-asserted-by":"crossref","unstructured":"Mercader M, Nickoloff BJ, Foreman KE. Induction of human immunodeficiency virus 1 replication by human herpesvirus 8. Arch Pathol Lab Med.2001;125: 785-789.","DOI":"10.5858\/2001-125-0785-IOHIVR"},{"key":"2020021215445499900_REF57","doi-asserted-by":"crossref","unstructured":"Huang LM, Chao MF, Chen MY, et al. Reciprocal regulatory interaction between human herpesvirus 8 and human immunodeficiency virus type 1. J Biol Chem.2001;276: 13427-13432.","DOI":"10.1074\/jbc.M011314200"},{"key":"2020021215445499900_REF58","doi-asserted-by":"crossref","unstructured":"Pati S, Foulke JS Jr, Barabitskaya O, et al. Human herpesvirus 8-encoded vGPCR activates nuclear factor of activated T cells and collaborates with human immunodeficiency virus type 1 Tat. J Virol.2003;77: 5759-5773.","DOI":"10.1128\/JVI.77.10.5759-5773.2003"},{"key":"2020021215445499900_REF59","doi-asserted-by":"crossref","unstructured":"Roth WK, Brandstetter H, Sturzl M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS.1992;6: 895-913.","DOI":"10.1097\/00002030-199209000-00001"},{"key":"2020021215445499900_REF60","doi-asserted-by":"crossref","unstructured":"Conaldi PG, Serra C, Dolei A, et al. Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha. J Med Virol.1995;47: 355-363.","DOI":"10.1002\/jmv.1890470411"},{"key":"2020021215445499900_REF61","doi-asserted-by":"crossref","unstructured":"Dezube BJ, Zambela M, Sage DR, Wang JF, Fingeroth JD. Characterization of Kaposi sarcoma-associated herpesvirus\/human herpesvirus-8 infection of human vascular endothelial cells: early events. Blood.2002;100: 888-896.","DOI":"10.1182\/blood.V100.3.888"},{"key":"2020021215445499900_","doi-asserted-by":"crossref","unstructured":"Moses AV, Fish KN, Ruhl R, et al. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8. J Virol.1999;73: 6892-6902.","DOI":"10.1128\/JVI.73.8.6892-6902.1999"},{"key":"2020021215445499900_REF63","doi-asserted-by":"crossref","unstructured":"Gao SJ, Deng JH, Zhou FC. Productive lytic replication of a recombinant Kaposi's sarcoma-associated herpesvirus in efficient primary infection of primary human endothelial cells. J Virol.2003;77: 9738-9749.","DOI":"10.1128\/JVI.77.18.9738-9749.2003"},{"key":"2020021215445499900_REF64","doi-asserted-by":"crossref","unstructured":"Chung YH, Means RE, Choi JK, Lee BS, Jung JU. Kaposi's sarcoma-associated herpesvirus OX2 glycoprotein activates myeloid-lineage cells to induce inflammatory cytokine production. J Virol.2002;76: 4688-4698.","DOI":"10.1128\/JVI.76.10.4688-4698.2002"},{"key":"2020021215445499900_REF65","doi-asserted-by":"crossref","unstructured":"An J, Lichtenstein AK, Brent G, Rettig MB. The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood.2002;99: 649-654.","DOI":"10.1182\/blood.V99.2.649"},{"key":"2020021215445499900_REF66","doi-asserted-by":"crossref","unstructured":"Quinlivan EB, Zhang C, Stewart PW, Komoltri C, Davis MG, Wehbie RS. Elevated virus loads of Kaposi's sarcoma-associated human herpesvirus 8 predict Kaposi's sarcoma disease progression, but elevated levels of human immunodeficiency virus type 1 do not. J Infect Dis.2002;185: 1736-1744.","DOI":"10.1086\/340652"},{"key":"2020021215445499900_REF67","doi-asserted-by":"crossref","unstructured":"Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS.2003;17: 1847-1851.","DOI":"10.1097\/00002030-200308150-00015"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2790\/1635284\/zh802005002790.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/106\/8\/2790\/1635284\/zh802005002790.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:35:43Z","timestamp":1683120943000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/106\/8\/2790\/21781\/Human-herpesvirus-8-enhances-human"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,15]]},"references-count":67,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2005,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2005-04-1390","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10,15]]}}}